Shop MDUK Professionals

Helpline 0800 652 6352

Helpline 0800 652 6352

NEWS and UPDATES

Researchers are finally starting to find treatments which slow progression for people with muscle wasting and weakening conditions. Promising treatments, like givinostat for Duchenne muscular dystrophy, are now within reach – but not enough people can access them. We’re working tirelessly to change this, to ensure everyone gets the treatment they need, when they need it.

ALL NEWS

Filter by type

Givinostat – our role in supporting access to new treatments

Building a legacy: Over £8 million raised by property sector fundraising event

Our auction for London’s hottest ticket: You Me Bum Bum Train

Accelerating the development of treatments for congenital muscular dystrophy – our £1 million partnership with LifeArc

New drug in development for primary mitochondrial myopathies

New Muscle Groups dates announced

We’re calling on the UK Government to tackle the challenges faced by people with muscle wasting and weakening conditions in its upcoming 10 Year Health Plan

Translarna, a treatment for Duchenne muscular dystrophy, remains available in the UK

Our brand NEW podcast now available

Lifechanging grants for children – our new partnership with Whizz Kidz

DMD Care UK webinar for patients and families about vamorolone

Proposed welfare reforms and benefits cuts: what do we know about how this will affect people with muscle wasting and weakening conditions?